FMR LLC
- SEC CIK
- 0000315066
- Latest filing
- Aug 13, 2026
HOWL holding history
Werewolf Therapeutics, Inc. in every 13F filed by FMR LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HOWL overviewAll 13F holders of HOWLFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −39−100.0% | Sold out | Holders |
| Q1 2026 | 39 | $32 | <0.1% | −3,592−98.9% | Reduced | Holders |
| Q4 2025 | 3,631 | $2.30K | <0.1% | −7,653−67.8% | Reduced | Holders |
| Q3 2025 | 11,284 | $22.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 11,284 | $12.3K | <0.1% | +6,823+152.9% | Added | Holders |
| Q1 2025 | 4,461 | $4.34K | <0.1% | +2,630+143.6% | Added | Holders |
| Q4 2024 | 1,831 | $2.71K | <0.1% | +317+20.9% | Added | Holders |
| Q3 2024 | 1,514 | $3.21K | <0.1% | +1,511+50,366.7% | Added | Holders |
| Q2 2024 | 3 | $7 | <0.1% | +3 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −2,100−100.0% | Sold out | Holders |
| Q2 2023 | 2,100 | $6.41K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 2,100 | $5.46K | <0.1% | +2,100 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −337,073−100.0% | Sold out | Holders |
| Q3 2022 | 337,073 | $1.52M | <0.1% | −181,699−35.0% | Reduced | Holders |
| Q2 2022 | 518,772 | $2.12M | <0.1% | +1370.0% | Added | Holders |
| Q1 2022 | 518,635 | $2.28M | <0.1% | +147,901+39.9% | Added | Holders |
| Q4 2021 | 370,734 | $4.42M | <0.1% | +132,234+55.4% | Added | Holders |
| Q3 2021 | 238,500 | $4.09M | <0.1% | −76,500−24.3% | Reduced | Holders |
| Q2 2021 | 315,000 | $5.49M | <0.1% | +315,000 | New | Holders |